Benjamin Howden
Benjamin Howden
Professor and Director, Microbiological Diagnostic Unit, University of Melbourne at The Doherty
Verified email at unimelb.edu.au - Homepage
Title
Cited by
Cited by
Year
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains …
BP Howden, JK Davies, PDR Johnson, TP Stinear, ML Grayson
Clinical microbiology reviews 23 (1), 99-139, 2010
10332010
Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
BP Howden, PB Ward, PGP Charles, TM Korman, A Fuller, P Du Cros, ...
Clinical Infectious Diseases 38 (4), 521-528, 2004
5572004
Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
PGP Charles, PB Ward, PDR Johnson, BP Howden, ML Grayson
Clinical infectious diseases 38 (3), 448-451, 2004
4422004
Members of the Fusarium solani Species Complex That Cause Infections in Both Humans and Plants Are Common in the Environment
N Zhang, K O'Donnell, DA Sutton, FA Nalim, RC Summerbell, AA Padhye, ...
Journal of Clinical Microbiology 44 (6), 2186-2190, 2006
3602006
Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
BP Howden, CRE McEvoy, DL Allen, K Chua, W Gao, PF Harrison, J Bell, ...
PLoS pathogens 7 (11), e1002359, 2011
2762011
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Journal of Infectious Diseases 204 (3), 340-347, 2011
2532011
Whole genome sequencing in clinical and public health microbiology
JC Kwong, N McCallum, V Sintchenko, BP Howden
Pathology 47 (3), 199-210, 2015
2472015
Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
BP Howden, PDR Johnson, PB Ward, TP Stinear, JK Davies
Antimicrobial Agents and Chemotherapy 50 (9), 3039-3047, 2006
2422006
Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand
JD Turnidge, D Kotsanas, W Munckhof, S Roberts, CM Bennett, ...
Medical Journal of Australia 191 (7), 368-373, 2009
2342009
Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs
ML Grayson, SM Crowe, JS McCarthy, J Mills, JW Mouton, SR Norrby, ...
CRC Press, 2010
233*2010
Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine
BP Howden, MA Slavin, AP Schwarer, AM Mijch
European Journal of Clinical Microbiology and Infectious Diseases 22 (2 …, 2003
2142003
Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia
L Caly, J Druce, J Roberts, K Bond, T Tran, R Kostecki, Y Yoga, ...
Medical Journal of Australia 212 (10), 459-462, 2020
2122020
Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection
W Gao, K Chua, JK Davies, HJ Newton, T Seemann, PF Harrison, ...
PLoS pathogens 6 (6), e1000944, 2010
2102010
Dumb and Dumber—The Potential Waste of a Useful Antistaphylococcal Agent: Emerging Fusidic Acid Resistance in Staphylococcus aureus
BP Howden, ML Grayson
Clinical Infectious Diseases 42 (3), 394-400, 2006
2052006
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
A Poudyal, BP Howden, JM Bell, W Gao, RJ Owen, JD Turnidge, ...
Journal of Antimicrobial Chemotherapy 62 (6), 1311-1318, 2008
1872008
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Antimicrobial agents and chemotherapy 57 (4), 1654-1663, 2013
1862013
Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients
E Bishop, S Melvani, BP Howden, PGP Charles, ML Grayson
Antimicrobial agents and chemotherapy 50 (4), 1599-1602, 2006
1802006
Prospective whole-genome sequencing enhances national surveillance of Listeria monocytogenes
JC Kwong, K Mercoulia, T Tomita, M Easton, HY Li, DM Bulach, ...
Journal of clinical microbiology 54 (2), 333-342, 2016
1762016
Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns
DA Williamson, GP Carter, BP Howden
Clinical microbiology reviews 30 (3), 827-860, 2017
1752017
Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study
KS Baker, TJ Dallman, PM Ashton, M Day, G Hughes, PD Crook, ...
The Lancet infectious diseases 15 (8), 913-921, 2015
1602015
The system can't perform the operation now. Try again later.
Articles 1–20